Customize your JAMA Network experience by selecting one or more topics from the list below.
In the Preliminary Communication entitled “Sofosbuvir and Ribavirin for Hepatitis C Genotype 1 in Patients With Unfavorable Treatment Characteristics: A Randomized Clinical Trial” in the August 28, 2013, issue of JAMA (2013;210:804-811 doi:10.1001/JAMA.2013.109309), the figure had an error. In the right-hand box following the randomization oval, it should have read that 25 patients received “400 mg/d of sofosbuvir.” This article has been corrected online.
Error in Figure. JAMA. 2013;310(18):1987. doi:10.1001/jama.2013.281319
Coronavirus Resource Center
Create a personal account or sign in to: